In a breakthrough for cardiovascular medicine, researchers have harnessed artificial intelligence to discover unexpected lipid-lowering effects in existing FDA-approved drugs. The study, published in ...
One of the world’s largest studies on the impact of cholesterol-lowering medication has highlighted an issue with a new class of drugs that could impair lung function in some patients. Image Credit: ...
In a new translational research study published in Cancer Research, investigators at Beth Israel Deaconess Medical Center (BIDMC) explored the potential of statins—commonly used medications for ...
When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.
A new study confirms a protective effect of statin cholesterol-lowering drugs on liver cancer risk and suggests a similar effect with nonstatin cholesterol absorption inhibitors. Ever use of ...
PHILADELPHIA -- A novel anti-PCSK9 monoclonal antibody with a distinctive longer duration of action reduced cholesterol and other lipids in the phase III REMAIN-2 trial. Recaticimab showed long-term ...
Share on Pinterest Scientists have found a link between cholesterol absorption inhibitors and liver cancer. Sergii Kolesnikov/Getty Images Out of five non-statin cholesterol-lowering drug classes, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results